by Kevin Robb | Jun 29, 2023
Mesenchymal stromal cells (MSCs) have been at the front line of cell therapy and regenerative medicine efforts for decades. Investigators hotly pursued MSCs as prospective cell therapies for a wide range of diseases, but enthusiasts were left wanting when several...
by Sara M. Nolte | Jun 21, 2023
In addition to showers, flowers and warmer weather, this spring also brought renewed hope for patients with hematological malignancies undergoing stem cell transplants (SCTs) in the form of the approval of Gamida Cell’s Omisirge® (omidubicel). This cell-based therapy...
by Stacey Johnson | Jun 16, 2023
The definition of a rare disease in the U.S. is under 200,000 patients. The 10 per cent of Americans living with a rare disease is equivalent to 30 million people. Put another way, that is close to the entire population of Canada (at 39 million). There are 7,000 –...
by Stacey Johnson | Jun 9, 2023
Courtney Horvath, PhD, is a board certified toxicologist who knows firsthand about toxicity in pediatric oncology treatments. Her son, Colby, was diagnosed with lymphoma at the age of eight, in March 2020, and she has since become an advocate for better cancer...
by Stacey Johnson | Jun 2, 2023
The Networks of Centres of Excellence (NCE) program has been on my mind lately. Yes it’s true, although it may seem odd to admit. The Government of Canada’s innovative program, launched in 1989, was intended to “mobilize Canada’s best research, development and...
by Don Gibbons | May 25, 2023
A recent Wall Street Journal article reminded me of the work of someone I came to know well while at the California Institute for Regenerative Medicine (CIRM): Jeanne Loring of the Scripps Research Institute. The article detailed a cell therapy for Parkinson’s Disease...
by Cal Strode | May 18, 2023
Regular readers of Alliance for Regenerative Medicine (ARM) sector reports may have noticed that the organization is taking a new approach to sharing insights on the cell and gene therapy sector. In April, ARM launched a new format for distilling key data and trend...
by Francesco Zangari | May 10, 2023
CRISPR-Cas9 is not only a revolutionary technology, it is also a topic that never ceases to intrigue. From gene editing to agriculture, the possibilities are seemingly endless. In medicine, CRISPR-Cas9 has shown promising results in curing genetic blood disorders and...
by Don Gibbons | May 4, 2023
For people like me working in the biological science sector, the annual DNA Day (every April 25th) is always a cause to raise a toast, but this year was special. It marked the 70th anniversary of the discovery of the double helix by Watson and Crick (and Franklin) and...
by Cal Strode | Apr 27, 2023
The first Science Huddle panel discussion of 2023, Cell & Gene Therapy: Maximizing Commercialization, delved into challenges keeping leaders in the cell and gene therapy (CGT) commercialization space up at night. Moderating the event was Dr. Christian K....
Comments